The RPL35 antibody is a crucial tool for studying ribosomal protein L35 (RPL35), a component of the 60S large ribosomal subunit involved in protein synthesis. RPL35. encoded by the RPL35 gene, plays a role in ribosome assembly and translational fidelity. Dysregulation of RPL35 has been linked to various diseases, including cancers (e.g., hepatocellular carcinoma, colorectal cancer) and ribosomopathies, highlighting its importance in cellular homeostasis. The antibody specifically detects RPL35 in applications like Western blotting, immunohistochemistry, and immunofluorescence, enabling researchers to analyze its expression, localization, and interactions. Its utility extends to investigating ribosomal stress responses, cancer progression mechanisms, and potential therapeutic targets. Commercially available RPL35 antibodies are typically produced in hosts like rabbits or mice, targeting specific epitopes with validated specificity. Recent studies also explore its role in viral infections, where ribosomal proteins may influence pathogen replication. By facilitating precise detection, the RPL35 antibody supports advancements in understanding ribosome biology and disease pathology, bridging basic research and clinical applications.